Xultophy 100/3.6 Drug Interactions: 3 Major, 1281 Moderate
Xultophy 100/3.6 (Insulin Degludec And Liraglutide) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Xultophy 100/3.6. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Liraglutide.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Liraglutide.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Liraglutide is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Liraglutide.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Liraglutide is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Liraglutide.
Level 2 evidence
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin degludec.
Level 1 evidence
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Liraglutide.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Insulin degludec can be increased when used in combination with Acebutolol.
Level 1 evidence
Acebutolol
The therapeutic efficacy of Liraglutide can be increased when used in combination with Acebutolol.
Level 1 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Liraglutide is combined with Aceclofenac.
Level 2 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Liraglutide.
Xultophy 100/3.6 (Insulin Degludec And Liraglutide) has 1315 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Xultophy 100/3.6 (Insulin Degludec And Liraglutide) has 3 major, 1281 moderate, and 31 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Xultophy 100/3.6. Always confirm against the full prescribing information.